New developments and opportunities in oral mucosal drug delivery for local and systemic disease
- 1 March 2011
- journal article
- review article
- Published by Elsevier BV in Advanced Drug Delivery Reviews
- Vol. 64 (1), 16-28
- https://doi.org/10.1016/j.addr.2011.02.008
Abstract
No abstract availableKeywords
This publication has 112 references indexed in Scilit:
- Silk‐elastinlike protein polymers improve the efficacy of adenovirus thymidine kinase enzyme prodrug therapy of head and neck tumorsThe Journal of Gene Medicine, 2010
- The Current State of Head and Neck Cancer Gene TherapyHuman Gene Therapy, 2009
- Adenovirus Encoding Human Platelet-Derived Growth Factor-B Delivered to Alveolar Bone Defects Exhibits Safety and Biodistribution Profiles Favorable for Clinical UseHuman Gene Therapy, 2009
- Gene therapy: the end of the rainbow?Head & Neck Oncology, 2009
- AAV2/1-TNFR:Fc gene delivery prevents periodontal disease progressionGene Therapy, 2008
- Transdermal drug deliveryNature Biotechnology, 2008
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck CancerNew England Journal of Medicine, 2008
- Platelet‐derived growth factor‐B gene delivery sustains gingival fibroblast signal transductionJournal of Periodontal Research, 2008
- Sublingual vaccination with influenza virus protects mice against lethal viral infectionProceedings of the National Academy of Sciences, 2008
- EGFR and cancer prognosisEuropean Journal Of Cancer, 2001